Loralie Langman, PhD, DABCC, FACB, F-ABFT

Dr. Langman completed her PhD in Laboratory Medicine and Pathology at the University of Alberta, Canada. She completed her Clinical Chemistry training at the University of Toronto, specializing in Forensic Toxicology and Molecular Genetics.

She is a Fellow with the Canadian Academy of Clinical Biochemistry and is the first individual to have achieved Diplomat status with the American Board of Clinical Chemistry in all three disciplines (Clinical Chemistry, Molecular Diagnostics, and Toxicological Chemistry). She is also a Fellow with the American Board of Forensic Toxicology. She is currently one of the Directors of the Clinical and Forensic Toxicology Laboratory, Clinical Mass Spectroscopy Laboratory, and a Consultant for the Personalized Genomics Laboratory, Mayo Clinic Rochester, MN and Professor of Laboratory Medicine in Pathology, Mayo Clinic College of Medicine.

Her involvement with CLSI began when she chaired her first document development committee (DDC) in 2007. Since then she has been on three DDCs, served as a member of the Area Committee for Clinical Chemistry and Toxicology (now known as the Expert Panel on Clinical Chemistry and Toxicology) for four years, and then served as its Vice-Chairholder for four years. She is also a charter member of Consensus Council, which was formed in 2016.